CAS RN: 292636-11-4
7-AMino-5-chloroindole
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250919
250mg / 1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 292636-11-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>95%
0
Out of Stock
Hong Kong
Inquiry
292636-11-4 / 5-chloro-1H-indol-7-amine
Standard CAS: 292636-11-4
Multi CAS: No
Basic Information
copy
CAS
292636-11-4 copy
Multi CAS
No copy
Molecular Formula
C8H7CLN2 copy
Molecular Weight
166.610000 copy
Exact Mass
166.029776 copy
InChI
InChI=1S/C8H7ClN2/c9-6-3-5-1-2-11-8(5)7(10)4-6/h1-4,11H,10H2 copy
InChIKey
FJWGYGAHFUVAGI-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
H-bond acceptors
1 copy
H-bond donors
2 copy
Molar refractivity
47.72 copy
TPSA
41.81 copy
LogP / Solubility
WLOGP
2.4 copy
MLOGP
2.11 copy
XLogP3
2 copy
Consensus LogP
2.17 copy
Log S (ESOL)
-2.99 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.66 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.74 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.03 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy